{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:07Z","timestamp":1787028547716,"version":"build-2736575974"},"reference-count":222,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ELTE BDPK Excellence Program 12\/2023","award":["12\/2023"],"award-info":[{"award-number":["12\/2023"]}]},{"name":"Ketone Technologies","award":["12\/2023"],"award-info":[{"award-number":["12\/2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Approximately 30% of patients with epilepsy are drug-refractory. There is an urgent need to elucidate the exact pathophysiology of different types of epilepsies and the mechanisms of action of both antiseizure medication and metabolic therapies to treat patients more effectively and safely. For example, it has been demonstrated that exogenous ketone supplement (EKS)-generated therapeutic ketosis, as a metabolic therapy, may decrease epileptic activity in both animal models and humans, but its exact mechanism of action is unknown. However, it was demonstrated that therapeutic ketosis, among others, can increase adenosine level, which may enhance activity of A1 adenosine receptors (A1Rs) in the brain. It has also been demonstrated previously that adenosine has anti-epileptic effect through A1Rs in different models of epilepsies. Thus, it is possible that (i) therapeutic ketosis generated by the administration of EKSs may exert its anti-epileptic effect through, among other mechanisms, increased adenosine level and A1R activity and that (ii) the enhanced activity of A1Rs may be a necessary anti-epileptic mechanism evoked by EKS administration-generated ketosis. Moreover, EKSs can evoke and maintain ketosis without severe side effects. These results also suggest that the therapeutic application of EKS-generated ketosis may be a promising opportunity to treat different types of epilepsies. In this literature review, we specifically focus on the putative role of A1Rs in the anti-epileptic effect of EKS-induced ketosis.<\/jats:p>","DOI":"10.3390\/ijms25189869","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:15:27Z","timestamp":1726136127000},"page":"9869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Putative Role of Adenosine A1 Receptors in Exogenous Ketone Supplements-Evoked Anti-Epileptic Effect"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-5686","authenticated-orcid":false,"given":"Zsolt","family":"Kov\u00e1cs","sequence":"first","affiliation":[{"name":"Department of Biology, BDTTC, ELTE E\u00f6tv\u00f6s Lor\u00e1nd University, K\u00e1rolyi G\u00e1sp\u00e1r t\u00e9r 4., 9700 Szombathely, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151","family":"Rauch","sequence":"additional","affiliation":[{"name":"Department of Biology, BDTTC, ELTE E\u00f6tv\u00f6s Lor\u00e1nd University, K\u00e1rolyi G\u00e1sp\u00e1r t\u00e9r 4., 9700 Szombathely, Hungary"},{"name":"Institute of Biology, University of P\u00e9cs, Ifj\u00fas\u00e1g Str. 6, 7624 P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-181X","authenticated-orcid":false,"given":"Dominic P.","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Ketone Technologies LLC., Tampa, FL 33612, USA"},{"name":"Department of Molecular Pharmacology and Physiology, Laboratory of Metabolic Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA"},{"name":"Institute for Human and Machine Cognition, Ocala, FL 34471, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-823X","authenticated-orcid":false,"given":"Csilla","family":"Ari","sequence":"additional","affiliation":[{"name":"Ketone Technologies LLC., Tampa, FL 33612, USA"},{"name":"Department of Psychology, Behavioral Neuroscience Research Laboratory, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(00)00356-7","article-title":"Update on the pathophysiology of the epilepsies","volume":"177","author":"Ure","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2005.09.006","article-title":"Cellular and molecular mechanisms of epilepsy in the human brain","volume":"77","author":"Avoli","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1073858409354385","article-title":"Is epilepsy a preventable disorder? New evidence from animal models","volume":"16","author":"Giblin","year":"2010","journal-title":"Neuroscientist"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lindquist, B.E., Timbie, C., Voskobiynyk, Y., and Paz, J.T. (2023). Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets. Neurobiol. Dis., 181.","DOI":"10.1016\/j.nbd.2023.106094"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jocn.2008.10.001","article-title":"Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy\u2014Part 2","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jocn.2008.08.026","article-title":"Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy\u2014Part 1","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Lukasiuk","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/brain\/awaa072","article-title":"Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures","volume":"143","author":"Crunelli","year":"2020","journal-title":"Brain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(03)00265-5","article-title":"Cellular biology of epileptogenesis","volume":"2","author":"Avanzini","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Fattorusso, A., Matricardi, S., Mencaroni, E., Dell\u2019Isola, G.B., Di Cara, G., Striano, P., and Verrotti, A. (2021). The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.674483"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"301","author":"Potschka","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected","volume":"17","author":"Fedrowitz","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jpainsymman.2011.10.007","article-title":"Anti-epileptic drugs","volume":"42","author":"Howard","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s12098-020-03423-8","article-title":"Absence Seizures in Children: Usual and the Unusual","volume":"87","author":"Jain","year":"2020","journal-title":"Indian J. Pediatr."},{"key":"ref_20","unstructured":"WHO (2024, August 18). Fact sheet N 999 January. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs999\/en\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0301-0082(88)90028-7","article-title":"Purinergic mechanisms in epilepsy","volume":"31","author":"Dragunow","year":"1988","journal-title":"Prog. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","article-title":"Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy","volume":"44","author":"Gouder","year":"2003","journal-title":"Epilepsia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1523\/JNEUROSCI.4781-03.2004","article-title":"Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis","volume":"24","author":"Gouder","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1528-1167.2011.03337.x","article-title":"Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A(1)-receptor activation","volume":"53","author":"Hargus","year":"2012","journal-title":"Epilepsia"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Spanoghe, J., Larsen, L.E., Craey, E., Manzella, S., Van Dycke, A., Boon, P., and Raedt, R. (2020). The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010320"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14581\/jer.15001","article-title":"Pharmacoresistant epilepsy: A current update on non-conventional pharmacological and non-pharmacological interventions","volume":"5","author":"Sharma","year":"2015","journal-title":"J. Epilepsy Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2017.04.010","article-title":"Ischemic preconditioning with a ketogenic diet improves brain ischemic tolerance through increased extracellular adenosine levels and hypoxia-inducible factors","volume":"1667","author":"Yang","year":"2017","journal-title":"Brain Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1523\/JNEUROSCI.0055-10.2010","article-title":"Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels","volume":"30","author":"Kawamura","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI57813","article-title":"A ketogenic diet suppresses seizures in mice through adenosine A1 receptors","volume":"121","author":"Masino","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eplepsyres.2011.07.014","article-title":"Purines and neuronal excitability: Links to the ketogenic diet","volume":"100","author":"Masino","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/bph.16094","article-title":"The role of the adenosine system in epilepsy and its comorbidities","volume":"181","author":"Baltos","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0306-4522(87)92961-7","article-title":"The distribution of adenosine A1 receptors and 5\u2032-nucleotidase in the brain of some commonly used experimental animals","volume":"22","author":"Fastbom","year":"1987","journal-title":"Neuroscience"},{"key":"ref_34","first-page":"315","article-title":"Uneven regional distribution of nucleotide metabolism in human brain","volume":"6","author":"Dobolyi","year":"1998","journal-title":"Neurobiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11064-009-0080-z","article-title":"Nucleoside map of the human central nervous system","volume":"35","author":"Dobolyi","year":"2010","journal-title":"Neurochem. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2174\/156802611795347636","article-title":"Area, age and gender dependence of the nucleoside system in the brain: A review of current literature","volume":"11","author":"Palkovits","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Masino, S.A., and Boison, D. (2013). Anatomical distribution of nucleoside system in the human brain and implications for therapy. Adenosine: A Key Link between Metabolism and Brain Activity, Springer Science, Business Media.","DOI":"10.1007\/978-1-4614-3903-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/156802611795347627","article-title":"Adenosine and ATP receptors in the brain","volume":"11","author":"Burnstock","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2174\/156802611795347654","article-title":"The role of adenosine in the regulation of sleep","volume":"11","author":"Huang","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2174\/1381612819666131119154505","article-title":"The antiepileptic potential of nucleosides","volume":"21","author":"Dobolyi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Beamer, E., Kuchukulla, M., Boison, D., and Engel, T. (2021). ATP and adenosine-Two players in the control of seizures and epilepsy development. Prog. Neurobiol., 204.","DOI":"10.1016\/j.pneurobio.2021.102105"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000186688","article-title":"Molecular mechanisms of Go signaling","volume":"17","author":"Jiang","year":"2009","journal-title":"Neurosignals"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of Adenosine Receptors: The State of the Art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1523\/JNEUROSCI.22-04-01480.2002","article-title":"Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats","volume":"22","author":"Meeren","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainresbull.2013.05.009","article-title":"Uridine modulates neuronal activity and inhibits spike-wave discharges of absence epileptic Long Evans and Wistar Albino Glaxo\/Rijswijk rats","volume":"97","author":"Bali","year":"2013","journal-title":"Brain Res. Bull."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2004.04.015","article-title":"Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy","volume":"47","author":"Avsar","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1528-1167.2012.03724.x","article-title":"Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A(1) receptors in naive and chronic epileptic rats","volume":"53","author":"Klaft","year":"2012","journal-title":"Epilepsia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/epi.12511","article-title":"Increased cortical extracellular adenosine correlates with seizure termination","volume":"55","author":"Bower","year":"2014","journal-title":"Epilepsia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.47.4.568","article-title":"Changes in brain adenosine during bicuculline-induced seizures in rats. Effects of hypoxia and altered systemic blood pressure","volume":"47","author":"Winn","year":"1980","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410320504","article-title":"Adenosine: A potential mediator of seizure arrest and postictal refractoriness","volume":"32","author":"During","year":"1992","journal-title":"Ann. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1073\/pnas.1120997109","article-title":"Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity","volume":"109","author":"Lovatt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109172","DOI":"10.1016\/j.neuropharm.2022.109172","article-title":"Adenosine is released during thalamic oscillations to provide negative feedback control","volume":"216","author":"Wall","year":"2022","journal-title":"Neuropharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/0024-3205(87)90595-9","article-title":"Effects of bicuculline-induced seizures on benzodiazepine and adenosine receptors in developing rat brain","volume":"41","author":"Daval","year":"1987","journal-title":"Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3940(93)90217-9","article-title":"Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study","volume":"163","author":"Angelatou","year":"1993","journal-title":"Neurosci. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2004.11.004","article-title":"Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: Effects of angiotensin IV","volume":"1032","author":"Tchekalarova","year":"2005","journal-title":"Brain Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jocn.2009.08.011","article-title":"Increased binding of inhibitory neuronal receptors in the hippocampus in kainate-treated rats with spontaneous limbic seizures","volume":"17","author":"Ohta","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1460-9568.2009.06897.x","article-title":"Altered distribution and function of A2A adenosine receptors in the brain of WAG\/Rij rats with genetic absence epilepsy, before and after appearance of the disease","volume":"30","author":"Citraro","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-6147(00)01517-0","article-title":"Fine-tuning neuromodulation by adenosine","volume":"21","author":"Sebastiao","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0896-6273(95)90181-7","article-title":"Purinergic inhibition of GABA and glutamate release in the thalamus: Implications for thalamic network activity","volume":"15","author":"Ulrich","year":"1995","journal-title":"Neuron"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neuroscience.2005.10.022","article-title":"Adenosine A1 receptors decrease thalamic excitation of inhibitory and excitatory neurons in the barrel cortex","volume":"137","author":"Fontanez","year":"2006","journal-title":"Neuroscience"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2006.09.085","article-title":"A1 adenosine receptor-mediated modulation of neuronal ATP-sensitive K channels in rat substantia nigra","volume":"1124","author":"Andoh","year":"2006","journal-title":"Brain Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00585506","article-title":"Adenosine enhances afterhyperpolarization and accommodation in hippocampal pyramidal cells","volume":"402","author":"Haas","year":"1984","journal-title":"Pflugers Arch."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0306-4522(94)00518-A","article-title":"A1 adenosine receptors differentially regulate the N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated components of hippocampal excitatory postsynaptic current in a Ca2+\/Mg2+-dependent manner","volume":"65","author":"Klishin","year":"1995","journal-title":"Neuroscience"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874082001004010064","article-title":"Role of the purinergic neuromodulation system in epilepsy","volume":"4","author":"Silva","year":"2010","journal-title":"Open Neurosci. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2005.01.054","article-title":"Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus","volume":"133","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","article-title":"Neuronal voltage-gated calcium channels: Structure, function, and dysfunction","volume":"82","author":"Simms","year":"2014","journal-title":"Neuron"},{"key":"ref_70","first-page":"844","article-title":"Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain","volume":"267","author":"Concas","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/jnc.13872","article-title":"Hippocampal GABAergic transmission: A new target for adenosine control of excitability","volume":"139","author":"Rombo","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cercor\/bhu288","article-title":"Adenosine A1 Receptor Suppresses Tonic GABAA Receptor Currents in Hippocampal Pyramidal Cells and in a Defined Subpopulation of Interneurons","volume":"26","author":"Rombo","year":"2016","journal-title":"Cereb. Cortex."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.jcbfm.9600218","article-title":"Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury","volume":"26","author":"Kochanek","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.expneurol.2006.02.133","article-title":"Adenosine A1 receptors are crucial in keeping an epileptic focus localized","volume":"200","author":"Fedele","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jep.2009.11.002","article-title":"Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: Possible involvement of adenosine","volume":"127","author":"Rezvani","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.0953-816X.2004.03355.x","article-title":"Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner","volume":"19","author":"Etherington","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2012.02.012","article-title":"Endogenous adenosine induces NMDA receptor-independent persistent epileptiform discharges in dorsal and ventral hippocampus via activation of A2 receptors","volume":"100","author":"Moschovos","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neuroscience.2015.05.054","article-title":"Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats","volume":"300","author":"Dobolyi","year":"2015","journal-title":"Neuroscience"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., D\u2019Agostino, D.P., Dobolyi, A., and Ari, C. (2017). Adenosine A1 Receptor Antagonism Abolished the Anti-seizure Effects of Exogenous Ketone Supplementation in Wistar Albino Glaxo Rijswijk Rats. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00235"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1152\/jn.2000.83.4.1787","article-title":"Adenosine receptor antagonists induce persistent bursting in the rat hippocampal CA3 region via an NMDA receptor-dependent mechanism","volume":"83","author":"Dunwiddie","year":"2000","journal-title":"J. Neurophysiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(99)00132-6","article-title":"Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA\/2 mice","volume":"371","author":"Bertorelli","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1528-1167.2005.01027.x","article-title":"Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats","volume":"46","author":"Vianna","year":"2005","journal-title":"Epilepsia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(94)90032-9","article-title":"Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms","volume":"58","author":"Young","year":"1994","journal-title":"Neuroscience"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1023\/A:1025618324593","article-title":"Presynaptic modulation controlling neuronal excitability and epileptogenesis: Role of kainate, adenosine and neuropeptide Y receptors","volume":"28","author":"Malva","year":"2003","journal-title":"Neurochem. Res."},{"key":"ref_85","first-page":"70","article-title":"Sedative and anticonvulsant effects of adenosine analogs in mouse and rat","volume":"220","author":"Dunwiddie","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.bjp.0700869","article-title":"Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats","volume":"120","author":"Malhotra","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.expneurol.2004.07.017","article-title":"Focally injected adenosine prevents seizures in the rat","volume":"190","author":"Anschel","year":"2004","journal-title":"Exp. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2006.10.024","article-title":"Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats","volume":"1127","author":"Yildirim","year":"2007","journal-title":"Brain Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1528-1167.2010.02700.x","article-title":"Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures","volume":"51","author":"Raedt","year":"2010","journal-title":"Epilepsia"},{"key":"ref_90","first-page":"1229","article-title":"Adenosine A1 receptor activation mediates suppression of (-) bicuculline methiodide-induced seizures in rat prepiriform cortex","volume":"251","author":"Franklin","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(95)12064-B","article-title":"Opposite modulation of 4-aminopyridine and hypoxic hyperexcitability by A1 and A2 adenosine receptor ligands in rat hippocampal slices","volume":"200","author":"Longo","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-1211(01)00187-5","article-title":"Effects of chronic morphine and N6-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus","volume":"44","author":"Rocha","year":"2001","journal-title":"Epilepsy Res."},{"key":"ref_93","first-page":"559","article-title":"Individual and combined effects of N6-cyclopentyladenosine, flunarizine and diazepam on aminophylline-induced recurrent generalized seizures in mice","volume":"55","author":"Jaishree","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s11064-006-9275-8","article-title":"Differential expression of cerebellar metabotropic glutamate receptors mGLUR2\/3 and mGLUR4a after the administration of a convulsant drug and the adenosine analogue cyclopentyladenosine","volume":"32","author":"Girardi","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0014-2999(95)00557-9","article-title":"Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat","volume":"294","author":"Adami","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0028-3908(00)00203-3","article-title":"2-chloro-N6-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats","volume":"40","author":"Khan","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00702-010-0465-9","article-title":"Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors","volume":"117","year":"2010","journal-title":"J. Neural. Transm."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(85)91302-2","article-title":"Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: Morphological and electroencephalographic correlates","volume":"361","author":"Turski","year":"1985","journal-title":"Brain Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(91)90229-O","article-title":"Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate","volume":"553","author":"Ormandy","year":"1991","journal-title":"Brain Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/S0028-3908(00)00072-1","article-title":"Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures","volume":"39","author":"Khan","year":"2000","journal-title":"Neuropharmacology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.phrs.2007.04.011","article-title":"The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats","volume":"56","author":"Hosseinmardi","year":"2007","journal-title":"Pharmacol. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yebeh.2011.07.004","article-title":"Differential neuroprotection by A1 receptor activation and A2A receptor inhibition following pilocarpine-induced status epilepticus","volume":"22","author":"Rosim","year":"2011","journal-title":"Epilepsy Behav."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0028-3908(85)90010-3","article-title":"Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat","volume":"24","author":"Murray","year":"1985","journal-title":"Neuropharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.euroneuro.2004.05.006","article-title":"Adenosine A1 receptors and the anticonvulsant potential of drugs effective in the model of 3-nitropropionic acid-induced seizures in mice","volume":"15","author":"Zuchora","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1476-5381.1986.tb14587.x","article-title":"Adenosine inhibits epileptiform activity arising in hippocampal area CA3","volume":"87","author":"Ault","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0031-6989(88)80083-3","article-title":"Antiepileptic effects of N6-L-phenylisopropyladenosine (L-PIA) on penicillin-induced epileptogenic focus in rabbits","volume":"20","author":"Niglio","year":"1988","journal-title":"Pharmacol. Res. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0304-3940(84)90118-6","article-title":"Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats","volume":"46","author":"Barraco","year":"1984","journal-title":"Neurosci. Lett."},{"key":"ref_108","first-page":"313","article-title":"Effects of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures","volume":"277","author":"Bortolotto","year":"1985","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(97)00769-5","article-title":"Intra-amygdala infusion of 2-chloroadenosine suppresses amygdala-kindled seizures","volume":"775","author":"Pourgholami","year":"1997","journal-title":"Brain Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0920-1211(99)00025-X","article-title":"Anticonvulsant action of 2-chloroadenosine injected focally into the perirhinal cortex in amygdaloid kindled rats","volume":"37","author":"Pourgholami","year":"1999","journal-title":"Epilepsy Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(99)02425-7","article-title":"Intraperitoneal and intraamygdala N6-cyclohexyladenosine suppress hippocampal kindled seizures in rats","volume":"858","author":"Fathollahi","year":"2000","journal-title":"Brain Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-1211(01)00300-X","article-title":"Anticonvulsant effect of bilateral injection of N6-cyclohexyladenosine into the CA1 region of the hippocampus in amygdala-kindled rats","volume":"47","author":"Fathollahi","year":"2001","journal-title":"Epilepsy Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.biocel.2004.04.015","article-title":"Metabolic regulation of ATP breakdown and of adenosine production in rat brain extracts","volume":"36","author":"Barsotti","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0028-3908(94)90142-2","article-title":"Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices","volume":"33","author":"Pak","year":"1994","journal-title":"Neuropharmacology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0197-0186(94)00144-J","article-title":"Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices","volume":"26","author":"Lloyd","year":"1995","journal-title":"Neurochem. Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuropharm.2008.09.016","article-title":"Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus","volume":"56","author":"Etherington","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjp.0702881","article-title":"The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels","volume":"128","author":"Dupere","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ddr.430280341","article-title":"Manipulation of endogenous adenosine affects seizure susceptibility","volume":"28","author":"Murray","year":"1993","journal-title":"Drug Dev. Res."},{"key":"ref_119","first-page":"1415","article-title":"Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility","volume":"264","author":"Zhang","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0091-3057(02)00956-5","article-title":"Broad spectrum anticonvulsant activity of BW534U87: Possible role of an adenosine-dependent mechanism","volume":"74","author":"Southam","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_121","first-page":"1669","article-title":"Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy","volume":"289","author":"Wiesner","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2006.06.016","article-title":"Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme","volume":"142","author":"Studer","year":"2006","journal-title":"Neuroscience"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1073858404269112","article-title":"Adenosine and epilepsy: From therapeutic rationale to new therapeutic strategies","volume":"11","author":"Boison","year":"2005","journal-title":"Neuroscientist"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pneurobio.2007.12.002","article-title":"The adenosine kinase hypothesis of epileptogenesis","volume":"84","author":"Boison","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1528-1167.2011.03115.x","article-title":"Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1928","article-title":"Purinergic signalling in neuron-glia interactions","volume":"7","author":"Fields","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1152\/physrev.00049.2005","article-title":"Astrocyte control of synaptic transmission and neurovascular coupling","volume":"86","author":"Haydon","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/glia.20431","article-title":"Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission","volume":"55","author":"Perea","year":"2007","journal-title":"Glia"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nm1277","article-title":"An astrocytic basis of epilepsy","volume":"11","author":"Tian","year":"2005","journal-title":"Nat. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2012.03703.x","article-title":"Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: Role of astroglia","volume":"53","author":"Heinemann","year":"2012","journal-title":"Epilepsia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.neuint.2013.01.028","article-title":"Glial adenosine kinase\u2014A neuropathological marker of the epileptic brain","volume":"63","author":"Aronica","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., Skatchkov, S.N., Veh, R.W., Szab\u00f3, Z., N\u00e9meth, K., Szab\u00f3, P.T., Kardos, J., and H\u00e9ja, L. (2022). Critical Role of Astrocytic Polyamine and GABA Metabolism in Epileptogenesis. Front. Cell Neurosci., 15.","DOI":"10.3389\/fncel.2021.787319"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., Skatchkov, S.N., Szab\u00f3, Z., Qahtan, S., M\u00e9ndez-Gonz\u00e1lez, M.P., Malpica-Nieves, C.J., Eaton, M.J., Kardos, J., and H\u00e9ja, L. (2022). Putrescine Intensifies Glu\/GABA Exchange Mechanism and Promotes Early Termination of Seizures. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158191"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"\u00c7ar\u00e7ak, N., Onat, F., and Sitnikova, E. (2023). Astrocytes as a target for therapeutic strategies in epilepsy: Current insights. Front. Mol. Neurosci., 16.","DOI":"10.3389\/fnmol.2023.1183775"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-8993(95)01313-X","article-title":"Loss of A1 adenosine receptors in human temporal lobe epilepsy","volume":"710","author":"Glass","year":"1996","journal-title":"Brain Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/00001756-199806220-00042","article-title":"Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy","volume":"9","author":"Ekonomou","year":"1998","journal-title":"Neuroreport"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1460-9568.2003.02815.x","article-title":"Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats","volume":"18","author":"Rebola","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jnr.490390507","article-title":"Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes","volume":"39","author":"Ciccarelli","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tips.2005.08.004","article-title":"Adenosine receptor signaling in the brain immune system","volume":"26","author":"Pacher","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1523\/JNEUROSCI.4271-03.2004","article-title":"A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis","volume":"24","author":"Tsutsui","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1158\/0008-5472.CAN-06-0365","article-title":"A1 adenosine receptors in microglia control glioblastoma-host interaction","volume":"66","author":"Synowitz","year":"2006","journal-title":"Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/ijms15022024","article-title":"Adenosine receptors: Expression, function and regulation","volume":"15","author":"Sheth","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Mart\u00ed Navia, A., Dal Ben, D., Lambertucci, C., Spinaci, A., Volpini, R., Marques-Morgado, I., Coelho, J.E., Lopes, L.V., Marucci, G., and Buccioni, M. (2020). Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists. Cells, 9.","DOI":"10.3390\/cells9071739"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1471-4159.1999.0720652.x","article-title":"The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex","volume":"72","author":"Wang","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000026433","article-title":"Cytokine effects on glutamate uptake by human astrocytes","volume":"7","author":"Hu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/brain\/awp177","article-title":"The cortical innate immune response increases local neuronal excitability leading to seizures","volume":"132","author":"Rodgers","year":"2009","journal-title":"Brain"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2011.05.015","article-title":"IL-1\u03b2 is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence","volume":"44","author":"Akin","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neuroscience.2006.02.023","article-title":"Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo\/Rijswijk rats","volume":"140","author":"Papp","year":"2006","journal-title":"Neuroscience"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresbull.2011.05.003","article-title":"Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG\/Rij rats","volume":"85","year":"2011","journal-title":"Brain Res. Bull."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2013.08.002","article-title":"A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes","volume":"76","author":"Gessi","year":"2013","journal-title":"Pharmacol Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(02)01478-7","article-title":"Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices","volume":"339","author":"Almeida","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/glia.22285","article-title":"Adenosine dysfunction in epilepsy","volume":"60","author":"Boison","year":"2012","journal-title":"Glia"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0014-4886(84)90212-7","article-title":"Adenosine modulation of amygdala kindling","volume":"84","author":"Dragunow","year":"1984","journal-title":"Exp. Neurol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2007.10.008","article-title":"Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism","volume":"78","author":"Akula","year":"2008","journal-title":"Epilepsy Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2008.08.071","article-title":"The effect of intra-arterial papaverine on ECoG activity in the ketamine anesthetized rat","volume":"445","author":"Karatas","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.05.003","article-title":"Adenosine uptake inhibitors","volume":"495","author":"Noji","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1734-1140(11)70573-4","article-title":"Therapeutic potential of adenosine analogues and conjugates","volume":"63","author":"Samsel","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2174\/1381612825666190716100509","article-title":"Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives","volume":"25","author":"Deb","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e00506","DOI":"10.1002\/prp2.506","article-title":"Therapeutic potential of adenosine kinase inhibition-Revisited","volume":"7","author":"Jarvis","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0006-2952(00)00570-0","article-title":"Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells","volume":"61","author":"Fredholm","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinergic Signal."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2174\/138161208784480090","article-title":"Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders","volume":"14","author":"Cunha","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2005.10.006","article-title":"Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats","volume":"15","author":"Zeraati","year":"2006","journal-title":"Seizure"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0899-9007(96)00409-1","article-title":"Potential of ketone body esters for parenteral and oral nutrition","volume":"13","author":"Brunengraber","year":"1997","journal-title":"Nutrition"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","article-title":"Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","article-title":"Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Ari, C., Kov\u00e1cs, Z., Juhasz, G., Murdun, C., Goldhagen, C.R., Koutnik, A.M., Poff, A.M., Kesl, S.L., and D\u2019Agostino, D.P. (2016). Exogenous ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo\/Rijswijk rats. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00137"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12986-016-0069-y","article-title":"Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats","volume":"13","author":"Kesl","year":"2016","journal-title":"Nutr. Metab."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Stubbs, B.J., Cox, P.J., Evans, R.D., Santer, P., Miller, J.J., Faull, O.K., Magor-Elliott, S., Hiyama, S., Stirling, M., and Clarke, K. (2017). On the Metabolism of Exogenous Ketones in Humans. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00848"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Bolyard, M.L., Graziano, C.M., Fontaine, K.R., Sayer, R.D., Fisher, G., and Plaisance, E.P. (2023). Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester\/Salt Formulation in Humans. Nutrients, 15.","DOI":"10.3390\/nu15234876"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/epi.17476","article-title":"Does the ketogenic ratio matter when using ketogenic diet therapy in pediatric epilepsy?","volume":"64","author":"Sharma","year":"2023","journal-title":"Epilepsia"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11064-016-2099-2","article-title":"\u03b2-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms","volume":"42","author":"Achanta","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2018.01.011","article-title":"Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?","volume":"133","author":"Simeone","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.2174\/0929867311320340003","article-title":"5\u2032-nucleotidases, nucleosides and their distribution in the brain: Pathological and therapeutic implications","volume":"20","author":"Dobolyi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1152\/ajpregu.00506.2012","article-title":"Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats","volume":"304","author":"Pilla","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1194\/jlr.R046599","article-title":"Ketone body therapy: From the ketogenic diet to the oral administration of ketone ester","volume":"55","author":"Hashim","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Rho, J.M., and D\u2019Agostino, D.P. (2019). Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01041"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1192\/j.eurpsy.2019.13","article-title":"Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders","volume":"63","author":"Morris","year":"2020","journal-title":"Eur. Psychiatry"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Saris, C.G.J., and Timmers, S. (2022). Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.947567"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1523\/JNEUROSCI.0132-07.2007","article-title":"Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels","volume":"27","author":"Ma","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/caff.2020.0011","article-title":"Adenosine and Ketogenic Treatments","volume":"10","author":"Ruskin","year":"2020","journal-title":"J. Caffeine Adenosine Res."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., D\u2019Agostino, D.P., Diamond, D.M., and Ari, C. (2019). Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00045"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/glia.23247","article-title":"Epilepsy and astrocyte energy metabolism","volume":"66","author":"Boison","year":"2018","journal-title":"Glia"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nut.2012.09.009","article-title":"Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: Estimated potential contribution to brain energy metabolism","volume":"29","author":"Fortier","year":"2013","journal-title":"Nutrition"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Brunner, B., Ari, C., D\u2019Agostino, D.P., and Kov\u00e1cs, Z. (2021). Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG\/Rij Rats. Nutrients, 13.","DOI":"10.3390\/nu13114082"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e13961","DOI":"10.14814\/phy2.13961","article-title":"Delaying latency to hyperbaric oxygen-induced CNS oxygen toxicity seizures by combinations of exogenous ketone supplements","volume":"7","author":"Ari","year":"2019","journal-title":"Physiol. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2015.05.023","article-title":"Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure","volume":"1618","author":"Viggiano","year":"2015","journal-title":"Brain Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.seizure.2016.01.003","article-title":"Different calorie restriction treatments have similar anti-seizure efficacy","volume":"35","author":"Viggiano","year":"2016","journal-title":"Seizure"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2016.08.002","article-title":"Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model","volume":"96","author":"Ciarlone","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jvim.15756","article-title":"A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs","volume":"34","author":"Berk","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Berk, B.A., Ottka, C., Hong Law, T., Packer, R.M.A., Wessmann, A., Bathen-N\u00f6then, A., Jokinen, T.S., Knebel, A., Tipold, A., and Lohi, H. (2022). Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.935430"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/vr.105410","article-title":"Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: A non-blinded, prospective clinical trial","volume":"187","author":"Molina","year":"2020","journal-title":"Vet. Rec."},{"key":"ref_193","first-page":"809151","article-title":"Marked Seizure Reduction after MCT Supplementation","volume":"2013","author":"Azzam","year":"2013","journal-title":"Case Rep. Neurol. Med."},{"key":"ref_194","first-page":"111","article-title":"Medium chain triglyceride oil ketogenic diets in the treatment of childhood epilepsy","volume":"32","author":"Clark","year":"1978","journal-title":"J. Hum. Nutr."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.21.11.1097","article-title":"Medium-chain triglycerides as a therapy for intractable childhood epilepsy","volume":"21","author":"Huttenlocher","year":"1971","journal-title":"Neurology"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1028415X.2022.2065816","article-title":"Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy\u2014A single-center open-label pilot study","volume":"26","author":"Rasmussen","year":"2023","journal-title":"Nutr. Neurosci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Yamanashi, T., Iwata, M., Kamiya, N., Tsunetomi, K., Kajitani, N., Wada, N., Iitsuka, T., Yamauchi, T., Miura, A., and Pu, S. (2017). Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-08055-1"},{"key":"ref_200","unstructured":"Masino, S.A. (2022). Neuroprotective and Behavioral Benefits of Exogenous Ketone Supplementation-Evoked Ketosis. Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease, Oxford Academic. [2nd ed.]."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Rushing, K.A., Bolyard, M.L., Kelty, T., Wieschhaus, N., Pavela, G., Rector, R.S., and Plaisance, E.P. (2023). Dietary ketone ester attenuates the accretion of adiposity and liver steatosis in mice fed a high-fat, high-sugar diet. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1165224"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., D\u2019Agostino, D.P., and Ari, C. (2018). Anxiolytic Effect of Exogenous Ketone Supplementation Is Abolished by Adenosine A1 Receptor Inhibition in Wistar Albino Glaxo\/Rijswijk Rats. Front. Behav. Neurosci., 12.","DOI":"10.3389\/fnbeh.2018.00029"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., D\u2019Agostino, D.P., Diamond, D., Kindy, M.S., Rogers, C., and Ari, C. (2019). Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature. Front. Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00363"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., Brunner, B., D\u2019Agostino, D.P., and Ari, C. (2020). Inhibition of adenosine A1 receptors abolished the nutritional ketosis-evoked delay in the onset of isoflurane-induced anesthesia in Wistar Albino Glaxo Rijswijk rats. BMC Anesthesiol., 20.","DOI":"10.1186\/s12871-020-0943-z"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., D\u2019Agostino, D.P., and Ari, C. (2023). Ketone supplementation abolished isoflurane anesthesia-induced elevation in blood glucose level and increased recovery time from anesthesia in Wistar Albino Glaxo Rijswijk rats. BMC Anesthesiol., 23.","DOI":"10.1186\/s12871-023-02000-8"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Rauch, E., Ari, C., D\u2019Agostino, D.P., and Kov\u00e1cs, Z. (2024). Exogenous Ketone Supplement Administration Abrogated Isoflurane-Anesthesia-Induced Increase in Blood Glucose Level in Female WAG\/Rij Rats. Nutrients, 16.","DOI":"10.3390\/nu16101477"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1194\/jlr.M046755","article-title":"Ketogenic diet sensitizes glucose control of hippocampal excitability","volume":"55","author":"Kawamura","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.24424","article-title":"Ketone bodies mediate antiseizure effects through mitochondrial permeability transition","volume":"78","author":"Kim","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic control of vesicular glutamate transport and release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/brain\/awv325","article-title":"Seizure control by decanoic acid through direct AMPA receptor inhibition","volume":"139","author":"Chang","year":"2016","journal-title":"Brain"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Rauch, E., Ari, C., and Kov\u00e1cs, Z. (2023). Dose-Dependent Beneficial Effect of Ketone Supplement-Evoked Ketosis on Anxiety Level in Female WAG\/Rij Rats: Sometimes Less Is More. Nutrients, 15.","DOI":"10.3390\/nu15204412"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, Z., Brunner, B., D\u2019Agostino, D.P., and Ari, C. (2021). Age- and Sex-Dependent Modulation of Exogenous Ketone Supplement-Evoked Effects on Blood Glucose and Ketone Body Levels in Wistar Albino Glaxo Rijswijk Rats. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.618422"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"112084","DOI":"10.1016\/j.fct.2021.112084","article-title":"Toxicological evaluation of the ketogenic ester bis hexanoyl (R)-1,3-butanediol: Subchronic toxicity in Sprague Dawley rats","volume":"150","author":"Stubbs","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","article-title":"Ketogenic diets: From cancer to mitochondrial diseases and beyond","volume":"46","author":"Branco","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Bostock, E.C., Kirkby, K.C., and Taylor, B.V. (2017). The Current Status of the Ketogenic Diet in Psychiatry. Front. Psychiatry, 8.","DOI":"10.3389\/fpsyt.2017.00043"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2007.00914.x","article-title":"Clinical aspects of the ketogenic diet","volume":"48","author":"Hartman","year":"2007","journal-title":"Epilepsia"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/oby.22051","article-title":"A Ketone Ester Drink Lowers Human Ghrelin and Appetite","volume":"26","author":"Stubbs","year":"2018","journal-title":"Obesity"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.clnu.2018.03.009","article-title":"Decreased ghrelin and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant epilepsy and maintained on the ketogenic diet","volume":"38","author":"Roli","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Buckinx, A., De Bundel, D., Kooijman, R., and Smolders, I. (2021). Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010053"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Poff, A.M., Ward, N., Seyfried, T.N., Arnold, P., and D\u2019Agostino, D.P. (2015). Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127407"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Ari, C., D\u2019Agostino, D.P., and Cha, B.J. (2024). Neuroregeneration Improved by Sodium-D,L-Beta-Hydroxybutyrate in Primary Neuronal Cultures. Pharmaceuticals, 17.","DOI":"10.3390\/ph17091160"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2319-4170.107152","article-title":"Dietary therapies for epilepsy","volume":"36","author":"Kossoff","year":"2013","journal-title":"Biomed. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/9869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:54:52Z","timestamp":1760111692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/9869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":222,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms25189869"],"URL":"https:\/\/doi.org\/10.3390\/ijms25189869","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}